Skip to content
Toggle main navigation
TEPHIConnect logo
TEPHIConnect logo
  • Home
  • About
    • About TEPHINET
    • About TEPHIConnect
    • Terms of Use and Privacy
  • How to Join
  • Why Join?
  • News
  • Events
  • Groups
  • Journals
    • BMC Medicine
    • BMC Medical Research Methodology
    • Clinical Epidemiology and Global Health
    • Emerging Microbes & Infections
    • Frontiers in Epidemiology
    • Global Health Journal
    • International Journal of Epidemiology
    • Online Library Journal
    • PLoS One
    • Science Direct Journal (Global Health)
    • Science Direct Journal (Clinical Epidemiology and Global Health)
    Log in
    Request to join

    News

    All
    abstract
    access to care
    acute febrile Illness
    adolescents
    adults
    afenet
    afghanistan
    africa
    african american
    alaskapox
    alumni spotlight
    amazon
    americas
    analysis
    antarctica
    See all

    Results (16)

    Characterising the changes in RSV epidemiology in Beijing, China during 2015–2023: results from a prospective, multi-centre, hospital-based surveillance and serology study

    Characterising the changes in RSV epidemiology in Beijing, China during 2015–2023: results from a prospective, multi-centre, hospital-based surveillance and serology study

    Background: Respiratory syncytial virus (RSV) has posed substantial morbidity and mortality burden to young children and older adults globally. The coronavirus disease 2019 (COVID-19) pandemic was reported to have altered RSV epidemiology and could have important implications for RSV prevention and control strategies. We aimed to compare RSV epidemiology in different phases of the COVID-19 pandemi
    April 1, 2024
    Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020–30: a modelling study

    Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020–30: a modelling study

    Background There have been declines in global immunisation coverage due to the COVID-19 pandemic. Recovery has begun but is geographically variable. This disruption has led to under-immunised cohorts and interrupted progress in reducing vaccine-preventable disease burden. There have, so far, been few studies of the effects of coverage disruption on vaccine effects. We aimed to quantify the effects
    March 15, 2024
    Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of

    Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of

    Estimates of demographic metrics are crucial to assess levels and trends of population health outcomes. The profound impact of the COVID-19 pandemic on populations worldwide has underscored the need for timely estimates to understand this unprecedented event within the context of long-term population health trends. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 provides
    March 15, 2024
    COVID-19 vaccine acceptance and its associated factors in the Western Pacific Region

    COVID-19 vaccine acceptance and its associated factors in the Western Pacific Region

    Background: COVID-19 vaccines effectively reduced the severity of the pandemic, but the mass rollout was challenged by vaccine hesitancy, which was related to heterogenous factors—such as religiosity, mistrust, and a lack of scientific knowledge—around the globe. Distinguishing these potential influencers and quantifying their impacts would help authorities to tailor strategies that boost vaccine
    February 19, 2024
    Impact of COVID-19 on essential service provision for reproductive, maternal, neonatal, and child health in the Southeast Asia region: a systematic review

    Impact of COVID-19 on essential service provision for reproductive, maternal, neonatal, and child health in the Southeast Asia region: a systematic review

    Background: There is increasing evidence that the COVID-19 pandemic has impacted adversely on the provision of essential health services globally. The Southeast Asia region (SEAR) has experienced extremely high rates of COVID-19 infection, with potential adverse impacts on provision of reproductive, maternal, neonatal, and child health (RMNCH) services.Methods: We conducted a systematic literature
    February 15, 2024
    Sleep quality among non-hospitalized COVID-19 survivors: a national cross-sectional study

    Sleep quality among non-hospitalized COVID-19 survivors: a national cross-sectional study

    Objectives: Insomnia is a common symptom after COVID-19 infection; however, its current evidence was among hospitalized COVID-19 patients. This study aimed to assess the prevalence of insomnia and identify its association with depression and anxiety among non-hospitalized COVID-19 recovered population.Methods: We conducted a cross-sectional online survey of 1,056 COVID-19 survivors within 6 months
    February 7, 2024
    Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing COVID-19-Related Thromboembolic Events Among Medicare Enrollees Aged ≥65 Years and Those with End Stage Renal Disease - United States, September 2022-March 2023

    Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing COVID-19-Related Thromboembolic Events Among Medicare Enrollees Aged ≥65 Years and Those with End Stage Renal Disease - United States, September 2022-March 2023

    This report describes how bivalent COVID-19 vaccines were nearly 50% effective in preventing COVID-19-related thromboembolic events among adults aged 65 and older and those on dialysis.
    January 11, 2024
    Heterogeneity of treatment effect of higher dose dexamethasone by geographic region (Europe vs. India) in patients with COVID-19 and severe hypoxemia – a post hoc evaluation of the COVID STEROID 2 trial

    Heterogeneity of treatment effect of higher dose dexamethasone by geographic region (Europe vs. India) in patients with COVID-19 and severe hypoxemia – a post hoc evaluation of the COVID STEROID 2 trial

    BackgroundIn the COVID-STEROID 2 trial there was suggestion of heterogeneity of treatment effects (HTE) between patients enrolled from Europe vs. India on the primary outcome. Whether there was HTE for the remaining patient-centred outcomes is unclear.MethodsIn this post hoc analysis of the COVID-STEROID 2 trial, which compared 12 mg vs. 6 mg dexamethasone in adults with COVID-19 and severe hypoxe
    January 10, 2024
    Efficacy and safety of MP1032 plus standard-of-care compared to standard-of-care in hospitalised patients with COVID-19: a multicentre, randomised double-blind, placebo-controlled phase 2a trial

    Efficacy and safety of MP1032 plus standard-of-care compared to standard-of-care in hospitalised patients with COVID-19: a multicentre, randomised double-blind, placebo-controlled phase 2a trial

    SARS-CoV-2 infections still have a significant impact on the global population. The existing vaccinations have contributed to reducing the severe disease courses, decreasing hospitalisations, and lowering the mortality rate. However, due to the variability of COVID-19 symptoms, the emergence of new variants and the uneven global distribution of vaccines there is still a great need for new therapy
    December 11, 2023
    Report spotlights inequalities in COVID vaccine access in poorer nations

    Report spotlights inequalities in COVID vaccine access in poorer nations

    New global survey data published in Health Affairs shows that half of unvaccinated respondents said they wanted a COVID-19 vaccine but were not able to obtain the shots, suggesting that unmet supply needs still drives low vaccine uptake in many low- and middle-income countries.The survey came from 15,696 respondents in 17 countries in Africa and the Western Pacific. Surveys were conducted from May
    December 7, 2023
    COVID-19 and migrants: lessons for pandemic preparedness from the Malaysian experience

    COVID-19 and migrants: lessons for pandemic preparedness from the Malaysian experience

    Aligning with global evidence related to migrants and COVID-19, the pandemic highlighted and exposed long-standing structural inequities in the context of migrant populations in Malaysia who experienced a disproportionate level of exposure to SARS-CoV-2 and COVID-19 morbidity, as well as exacerbated precarity during COVID-19 owing to disruptions to their livelihoods, health, and life.Continue read
    November 30, 2023
    Fact Check: UK stillbirth study falsely linked to COVID vaccination

    Fact Check: UK stillbirth study falsely linked to COVID vaccination

    A report on a rise of stillbirths and babies dying in early weeks of life did not examine any data on the mothers’ COVID-19 vaccination status, despite social media posts misleadingly linking the results to vaccination efforts.The annual report by researchers at Oxford and Leicester universities found perinatal mortality and stillbirth rates increased slightly across the UK in 2021 after years of
    November 6, 2023
    Serotonin levels are depleted in long Covid patients, study says, pointing to a potential cause for ‘brain fog’

    Serotonin levels are depleted in long Covid patients, study says, pointing to a potential cause for ‘brain fog’

    New research published on Monday in Cell implicates both interferons and serotonin in long Covid in a way that brings together those hypotheses and could also explain “brain fog,” or the neurocognitive difficulties people endure.Read the full story.
    October 16, 2023
    COVID-19 Epidemiology during Delta Variant Dominance Period in 45 High-Income Countries, 2020–2021

    COVID-19 Epidemiology during Delta Variant Dominance Period in 45 High-Income Countries, 2020–2021

    The SARS-CoV-2 Delta variant, first identified in October 2020, quickly became the dominant variant worldwide. We used publicly available data to explore the relationship between illness and death (peak case rates, death rates, case-fatality rates) and selected predictors (percentage vaccinated, percentage of the population >65 years, population density, testing volume, index of mitigation policie
    September 18, 2023
    Strategies That Promote Equity in COVID-19 Vaccine Uptake for Black Communities: a Review

    Strategies That Promote Equity in COVID-19 Vaccine Uptake for Black Communities: a Review

    This review offers a perspective of the real-time mobilization which highlights the early views and experiences toward mobilization. Black communities have had a high burden of COVID-19 cases, hospitalizations, and death, yet rates of COVID-19 vaccine uptake among Blacks lag behind other demographic groups. This has been due in part to vaccine hesitancy and multi-level issues around access to COVI
    August 25, 2023
    COVID-19 crisis interlinkage with past pandemics and their effects on food security

    COVID-19 crisis interlinkage with past pandemics and their effects on food security

    Background: Pandemics as health and humanitarian crises have exerted traceable impacts on food security. Almost all past and current pandemics have created a food crisis that affects a share of the global population and threaten global food security. With the more frequent outbreaks of emerging and re-emerging diseases or pandemics, this paper looks at the various types of impacts from the current
    August 7, 2023
    Contact
    TEPHINET Secretariat

    330 W Ponce de Leon Ave

    Decatur

    GA 30030

    USA

    tephinet@taskforce.org
    +1-404-371-0466
    Links
    • Training Programs in Epidemiology and Public Health Interventions Network (TEPHINET)
    • Privacy Policy
    Cookies
    Reselect cookie settings
    Community engagement platform by Hivebrite.